DEPARTMENT OF DEFENSE - CONGRESSIONALLY DIRECTED MEDICAL RESEARCH PROGRAMS

FY22 Technology/Therapeutic Development Award - Funding Level 2

The list of Fiscal Year 2022 Peer Reviewed Medical Research Program Technology/Therapeutic Development Award - Funding Level 2 applications recommended for funding is for informational purposes only. Identification on this list of applications recommended for funding is not intended to either confer a right to funding nor does it guarantee funding. The award of federal funds to support any of these applications is contingent upon successful negotiations and applicable federal policy.

Institution Principal Investigator
AcuraStem, Inc.Peter Sazani
Ceria Therapeutics, Inc.David Jackson
DTx PharmaArthur Suckow
FluGen, Inc.Pamuk Bilsel
Lungpacer Medical USA, Inc.Matthew Gani
Microvascular Therapeutics, LLCEmmanuelle Meuillet
Obsidio, Inc.Karen Dubbin
Olfax, LLCJonathan Beckwith
Rejuvenation Technologies, Inc.John Ramunas
safeBVM CorporationPrathamesh Prabhudesai
The Geneva FoundationYansong Li
The Ohio State UniversityJustin Baker
University of California San DiegoStephanie Cherqui
University of PittsburghLouis Falo

Last updated Thursday, January 5, 2023